Latest filing published 01 Apr 2026 for NEUROONE MEDICAL TECHNOLOGIES Corp, €9,920.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Mark Christianson is a declared insider of NEUROONE MEDICAL TECHNOLOGIES Corp (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 20 July 2017 to 31 March 2026, the count stands at 62 filings.
On the market, this insider has only sold: 25 sales, €492k in total. The rest of the record consists of 37 share grants. In 2026 alone, the filings show no purchases and 5 sales.
The newest entry dates from 1 April 2026: a share grant of €170, in NEUROONE MEDICAL TECHNOLOGIES Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 51 declarations